{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:51:35Z","timestamp":1792651895757,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Grant No 5\/4\/1-2\/2019-NCD-II"],"award-info":[{"award-number":["Grant No 5\/4\/1-2\/2019-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10067-022-06202-2","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T18:02:41Z","timestamp":1652292161000},"page":"2297-2308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"6202_CR1","doi-asserted-by":"publisher","unstructured":"Mony JT, Khorooshi R, Owens T (2014) Chemokine receptor expression by inflammatory T cells in EAE. Front Cell Neurosci. 8. https:\/\/doi.org\/10.3389\/fncel.2014.00187","DOI":"10.3389\/fncel.2014.00187"},{"key":"6202_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ijlh.13141","volume":"42","author":"S Watanabe","year":"2020","unstructured":"Watanabe S, Yamada Y, Murakami H (2020) Expression of Th1\/Th2 cell-related chemokine receptors on CD4(+) lymphocytes under physiological conditions. Int J Lab Hematol 42:68\u201376. https:\/\/doi.org\/10.1111\/ijlh.13141","journal-title":"Int J Lab Hematol"},{"key":"6202_CR3","doi-asserted-by":"publisher","unstructured":"Yamaguchi H, Hiroi M, Mori K, et al. (2021) Simultaneous expression of Th1- and Treg-associated chemokine genes and CD4+, CD8+, and Foxp3+ cells in the premalignant lesions of 4NQO-induced mouse tongue tumorigenesis. Cancers 13. https:\/\/doi.org\/10.3390\/cancers13081835","DOI":"10.3390\/cancers13081835"},{"key":"6202_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jlb.4ru0619-197r","volume":"106","author":"P Yang","year":"2019","unstructured":"Yang P, Qian FY, Zhang MF et al (2019) Th17 cell pathogenicity and plasticity in rheumatoid arthritis. J Leukoc Biol 106:1233\u20131240. https:\/\/doi.org\/10.1002\/jlb.4ru0619-197r","journal-title":"J Leukoc Biol"},{"key":"6202_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3389\/fimmu.2017.00949","volume":"8","author":"FSM Trist\u00e3o","year":"2017","unstructured":"Trist\u00e3o FSM, Rocha FA, Carlos D et al (2017) Th17-inducing cytokines IL-6 and IL-23 are crucial for granuloma formation during experimental paracoccidioidomycosis. Front Immunol 8:949. https:\/\/doi.org\/10.3389\/fimmu.2017.00949","journal-title":"Front Immunol"},{"key":"6202_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cmi.2017.128","volume":"15","author":"H Shen","year":"2018","unstructured":"Shen H, Chen ZW (2018) The crucial roles of Th17-related cytokines\/signal pathways in M. tuberculosis infection. Cell Mol Immunol 15:216\u2013225. https:\/\/doi.org\/10.1038\/cmi.2017.128","journal-title":"Cell Mol Immunol"},{"key":"6202_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nri3610","volume":"14","author":"Y Bordon","year":"2014","unstructured":"Bordon Y (2014) Spotting the troublemakers. Nat Rev Immunol 14:64\u201365. https:\/\/doi.org\/10.1038\/nri3610","journal-title":"Nat Rev Immunol"},{"key":"6202_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.20130301","volume":"211","author":"R Ramesh","year":"2014","unstructured":"Ramesh R, Kozhaya L, McKevitt K et al (2014) Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 211:89\u2013104. https:\/\/doi.org\/10.1084\/jem.20130301","journal-title":"J Exp Med"},{"key":"6202_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J et al (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639\u2013646. https:\/\/doi.org\/10.1038\/ni1467","journal-title":"Nat Immunol"},{"key":"6202_CR10","doi-asserted-by":"publisher","unstructured":"Celada LJ, Kropski JA, Herazo-Maya JD, et al. (2018) PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production. Sci Transl Med 10. https:\/\/doi.org\/10.1126\/scitranslmed.aar8356","DOI":"10.1126\/scitranslmed.aar8356"},{"key":"6202_CR11","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2147\/JIR.S355881","volume":"15","author":"K Singh","year":"2022","unstructured":"Singh K, Rathore U, Rai MK et al (2022) Novel Th17 lymphocyte populations, Th17.1 and PD1+Th17, are increased in Takayasu arteritis, and both Th17 and Th17.1 sub-populations associate with active disease. J Inflamm Res 15:1521\u20131541. https:\/\/doi.org\/10.2147\/JIR.S355881","journal-title":"J Inflamm Res"},{"key":"6202_CR12","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4317","volume":"15","author":"H Benham","year":"2013","unstructured":"Benham H, Norris P, Goodall J et al (2013) Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther 15:R136. https:\/\/doi.org\/10.1186\/ar4317","journal-title":"Arthritis Res Ther"},{"key":"6202_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10067-015-2961-7","volume":"34","author":"SK Raychaudhuri","year":"2015","unstructured":"Raychaudhuri SK, Saxena A, Raychaudhuri SP (2015) Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis. Clin Rheumatol 34:1019\u20131023. https:\/\/doi.org\/10.1007\/s10067-015-2961-7","journal-title":"Clin Rheumatol"},{"key":"6202_CR14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192048","volume":"217","author":"LS Taams","year":"2020","unstructured":"Taams LS (2020) Interleukin-17 in rheumatoid arthritis: trials and tribulations. J Exp Med 217:e20192048. https:\/\/doi.org\/10.1084\/jem.20192048","journal-title":"J Exp Med"},{"key":"6202_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","volume":"58","author":"K Nistala","year":"2008","unstructured":"Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR (2008) Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 58:875\u2013887. https:\/\/doi.org\/10.1002\/art.23291","journal-title":"Arthritis Rheum"},{"key":"6202_CR16","unstructured":"Clinical trial of secukinumab in juvenile psoriatic arthritis and enthesitis-related arthritis https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03031782 [Accessed on 09 March 2022]."},{"key":"6202_CR17","doi-asserted-by":"publisher","first-page":"14751","DOI":"10.1073\/pnas.1003852107","volume":"107","author":"K Nistala","year":"2010","unstructured":"Nistala K, Adams S, Cambrook H et al (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 107:14751\u201314756. https:\/\/doi.org\/10.1073\/pnas.1003852107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6202_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00109-014-1232-4","volume":"93","author":"R Jimeno","year":"2015","unstructured":"Jimeno R, Gomariz RP, Gar\u00edn M et al (2015) The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP. J Mol Med (Berl) 93:457\u2013467. https:\/\/doi.org\/10.1007\/s00109-014-1232-4","journal-title":"J Mol Med (Berl)"},{"key":"6202_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1189\/jlb.3A0714-327R","volume":"98","author":"R Jimeno","year":"2015","unstructured":"Jimeno R, Leceta J, Gar\u00edn M et al (2015) Th17 polarization of memory Th cells in early arthritis: the vasoactive intestinal peptide effect. J Leukoc Biol 98:257\u2013269. https:\/\/doi.org\/10.1189\/jlb.3A0714-327R","journal-title":"J Leukoc Biol"},{"key":"6202_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s13075-015-0800-5","volume":"17","author":"SM Paulissen","year":"2015","unstructured":"Paulissen SM, van Hamburg JP, Davelaar N et al (2015) CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis. Arthritis Res Ther 17:344. https:\/\/doi.org\/10.1186\/s13075-015-0800-5","journal-title":"Arthritis Res Ther"},{"key":"6202_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2017.10.001","volume":"88","author":"LE Jeffery","year":"2018","unstructured":"Jeffery LE, Henley P, Marium N et al (2018) Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint. J Autoimmun 88:50\u201360. https:\/\/doi.org\/10.1016\/j.jaut.2017.10.001","journal-title":"J Autoimmun"},{"key":"6202_CR22","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3389\/fimmu.2019.01504","volume":"10","author":"W Dankers","year":"2019","unstructured":"Dankers W, Davelaar N, van Hamburg JP, van de Peppel J, Colin EM, Lubberts E (2019) Human memory Th17 cell populations change into anti-inflammatory cells with regulatory capacity upon exposure to active vitamin D. Front Immunol 10:1504. https:\/\/doi.org\/10.3389\/fimmu.2019.01504","journal-title":"Front Immunol"},{"key":"6202_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13075-021-02532-9","volume":"23","author":"W Dankers","year":"2021","unstructured":"Dankers W, den Braanker H, Paulissen SMJ et al (2021) The heterogeneous human memory CCR6+ T helper-17 populations differ in T-bet and cytokine expression but all activate synovial fibroblasts in an IFN\u03b3-independent manner. Arthritis Res Ther 23:157. https:\/\/doi.org\/10.1186\/s13075-021-02532-9","journal-title":"Arthritis Res Ther"},{"key":"6202_CR24","doi-asserted-by":"publisher","first-page":"e0215192","DOI":"10.1371\/journal.pone.0215192","volume":"14","author":"S Maeda","year":"2019","unstructured":"Maeda S, Osaga S, Maeda T et al (2019) Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: an exploratory research. PLoS One 14:e0215192. https:\/\/doi.org\/10.1371\/journal.pone.0215192","journal-title":"PLoS One"},{"key":"6202_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2016.08.026","volume":"99","author":"T Abimannan","year":"2016","unstructured":"Abimannan T, Peroumal D, Parida JR, Barik PK, Padhan P, Devadas S (2016) Oxidative stress modulates the cytokine response of differentiated Th17 and Th1 cells. Free Radic Biol Med 99:352\u2013363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.08.026","journal-title":"Free Radic Biol Med"},{"key":"6202_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.clim.2016.10.003","volume":"173","author":"T Koga","year":"2016","unstructured":"Koga T, Sato T, Umeda M et al (2016) Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: impact of this JAK inhibitor on T-cell differentiation. Clin Immunol 173:147\u2013148. https:\/\/doi.org\/10.1016\/j.clim.2016.10.003","journal-title":"Clin Immunol"},{"key":"6202_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13075-021-02714-5","volume":"24","author":"H den Braanker","year":"2022","unstructured":"den Braanker H, Razawy W, Wervers K et al (2022) Characterizing memory T helper cells in patients with psoriasis, subclinical, or early psoriatic arthritis using a machine learning algorithm. Arthritis Res Ther 24:28. https:\/\/doi.org\/10.1186\/s13075-021-02714-5","journal-title":"Arthritis Res Ther"},{"key":"6202_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/thx.2010.140319","volume":"66","author":"M Facco","year":"2011","unstructured":"Facco M, Cabrelle A, Teramo A et al (2011) Sarcoidosis is a Th1\/Th17 multisystem disorder. Thorax 66:144. https:\/\/doi.org\/10.1136\/thx.2010.140319","journal-title":"Thorax"},{"key":"6202_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4997\/jrcpe.2020.304","volume":"50","author":"A Jain","year":"2020","unstructured":"Jain A, Singh H, Nath A et al (2020) Distinct T-cell immunophenotypic signature in a subset of sarcoidosis patients with arthritis. J R Coll Physicians Edinb 50:226\u2013232. https:\/\/doi.org\/10.4997\/jrcpe.2020.304","journal-title":"J R Coll Physicians Edinb"},{"key":"6202_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","volume":"193","author":"J Ramstein","year":"2016","unstructured":"Ramstein J, Broos CE, Simpson LJ et al (2016) IFN-\u03b3-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells. Am J Respir Crit Care Med 193:1281\u20131291. https:\/\/doi.org\/10.1164\/rccm.201507-1499OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6202_CR31","doi-asserted-by":"publisher","first-page":"1701124","DOI":"10.1183\/13993003.01124-2017","volume":"51","author":"CE Broos","year":"2018","unstructured":"Broos CE, Koth LL, van Nimwegen M et al (2018) Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes. Eur Respir J 51:1701124. https:\/\/doi.org\/10.1183\/13993003.01124-2017","journal-title":"Eur Respir J"},{"key":"6202_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3389\/fimmu.2020.01129","volume":"11","author":"NK Arger","year":"2020","unstructured":"Arger NK, Machiraju S, Allen IE, Woodruff PG, Koth LL (2020) T-bet expression in peripheral Th17.0 cells is associated with pulmonary function changes in sarcoidosis. Front Immunol 11:1129. https:\/\/doi.org\/10.3389\/fimmu.2020.01129","journal-title":"Front Immunol"},{"key":"6202_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/jlb.5a0321-162r","volume":"111","author":"R Lepzien","year":"2022","unstructured":"Lepzien R, Nie M, Czarnewski P et al (2022) Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFN\u03b3-producing Th1 cells compared with monocytes. J Leukoc Biol 111:857\u2013866. https:\/\/doi.org\/10.1002\/jlb.5a0321-162r","journal-title":"J Leukoc Biol"},{"key":"6202_CR34","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/1756-185x.13076","volume":"20","author":"AJ Lomax","year":"2017","unstructured":"Lomax AJ, McGuire HM, McNeil C et al (2017) Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: case series and immunophenotypic analysis. Int J Rheum Dis 20:1277\u20131285. https:\/\/doi.org\/10.1111\/1756-185x.13076","journal-title":"Int J Rheum Dis"},{"key":"6202_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056841","volume":"11","author":"LL Koth","year":"2021","unstructured":"Koth LL, Harmacek LD, White EK et al (2021) Defining CD4 T helper and T regulatory cell endotypes of progressive and remitting pulmonary sarcoidosis (BRITE): protocol for a US-based, multicentre, longitudinal observational bronchoscopy study. BMJ Open 11:e056841. https:\/\/doi.org\/10.1136\/bmjopen-2021-056841","journal-title":"BMJ Open"},{"key":"6202_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/1744666x.2019.1593141","volume":"15","author":"T Koga","year":"2019","unstructured":"Koga T, Ichinose K, Kawakami A, Tsokos GC (2019) The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target. Expert Rev Clin Immunol 15:629\u2013637. https:\/\/doi.org\/10.1080\/1744666x.2019.1593141","journal-title":"Expert Rev Clin Immunol"},{"key":"6202_CR37","doi-asserted-by":"publisher","first-page":"12962","DOI":"10.1038\/s41598-017-13344-w","volume":"7","author":"W Zhong","year":"2017","unstructured":"Zhong W, Jiang Y, Ma H, Wu J, Jiang Z, Zhao L (2017) Elevated levels of CCR6(+) T helper 22 cells correlate with skin and renal impairment in systemic lupus erythematosus. Sci Rep 7:12962. https:\/\/doi.org\/10.1038\/s41598-017-13344-w","journal-title":"Sci Rep"},{"key":"6202_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12865-015-0070-7","volume":"16","author":"A Zickert","year":"2015","unstructured":"Zickert A, Amoudruz P, Sundstr\u00f6m Y, R\u00f6nnelid J, Malmstr\u00f6m V, Gunnarsson I (2015) IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. BMC Immunol 16:7. https:\/\/doi.org\/10.1186\/s12865-015-0070-7","journal-title":"BMC Immunol"},{"key":"6202_CR39","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/1756-185x.13272","volume":"21","author":"S Shenoy","year":"2018","unstructured":"Shenoy S, Chaurasia S, Edavalath S et al (2018) Effect of induction therapy on circulating T-helper 17 and T-regulatory cells in active proliferative lupus nephritis. Int J Rheum Dis 21:1040\u20131048. https:\/\/doi.org\/10.1111\/1756-185x.13272","journal-title":"Int J Rheum Dis"},{"key":"6202_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cei.13196","volume":"194","author":"B Jakiela","year":"2018","unstructured":"Jakiela B, Kosa\u0142ka J, Plutecka H, Bazan-Socha S, Sanak M, Musia\u0142 J (2018) Facilitated expansion of Th17 cells in lupus nephritis patients. Clin Exp Immunol 194:283\u2013294. https:\/\/doi.org\/10.1111\/cei.13196","journal-title":"Clin Exp Immunol"},{"key":"6202_CR41","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4294","volume":"6","author":"W Zhong","year":"2018","unstructured":"Zhong W, Jiang Z, Wu J, Jiang Y, Zhao L (2018) CCR6(+) Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status. PeerJ 6:e4294. https:\/\/doi.org\/10.7717\/peerj.4294","journal-title":"PeerJ"},{"key":"6202_CR42","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","volume":"17","author":"K Psianou","year":"2018","unstructured":"Psianou K, Panagoulias I, Papanastasiou AD et al (2018) Clinical and immunological parameters of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 17:1053\u20131064. https:\/\/doi.org\/10.1016\/j.autrev.2018.05.005","journal-title":"Autoimmun Rev"},{"issue":"Suppl 133","key":"6202_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.55563\/clinexprheumatol\/tlnr4z","volume":"39","author":"X Peng","year":"2021","unstructured":"Peng X, Lu Y, Wei J et al (2021) A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome patients with dry eye disease. Clin Exp Rheumatol 39(Suppl 133):159\u2013165","journal-title":"Clin Exp Rheumatol"},{"key":"6202_CR44","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13287-021-02541-0","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Xing Y, Gan Y, He J, Hua H (2021) Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sj\u00f6gren\u2019s syndrome by modulating the balance of Treg and Th17 cells. Stem Cell Res Ther 12:478. https:\/\/doi.org\/10.1186\/s13287-021-02541-0","journal-title":"Stem Cell Res Ther"},{"key":"6202_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.clim.2016.03.005","volume":"165","author":"T Koga","year":"2016","unstructured":"Koga T, Mizokami A, Nakashima M et al (2016) Histological improvement in salivary gland along with effector memory Th17-1 cell reduction in a primary Sjogren\u2019s syndrome patient with dermatomyositis and diffuse large B-cell lymphoma by R-CHOP therapy. Clin Immunol 165:35\u201337. https:\/\/doi.org\/10.1016\/j.clim.2016.03.005","journal-title":"Clin Immunol"},{"key":"6202_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121441","volume":"283","author":"H Guo","year":"2022","unstructured":"Guo H, Ju Y, Choi M et al (2022) Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sj\u00f6gren\u2019s syndrome. Biomaterials 283:121441. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121441","journal-title":"Biomaterials"},{"key":"6202_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar2923","volume":"12","author":"B Wilde","year":"2010","unstructured":"Wilde B, Thewissen M, Damoiseaux J, van Paassen P, Witzke O, Tervaert JW (2010) T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther 12:204. https:\/\/doi.org\/10.1186\/ar2923","journal-title":"Arthritis Res Ther"},{"key":"6202_CR48","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1161\/circulationaha.109.872903","volume":"121","author":"J Deng","year":"2010","unstructured":"Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM (2010) Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 121:906\u2013915. https:\/\/doi.org\/10.1161\/circulationaha.109.872903","journal-title":"Circulation"},{"key":"6202_CR49","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/art.39037","volume":"67","author":"D Saadoun","year":"2015","unstructured":"Saadoun D, Garrido M, Comarmond C et al (2015) Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol 67:1353\u20131360. https:\/\/doi.org\/10.1002\/art.39037","journal-title":"Arthritis Rheumatol"},{"key":"6202_CR50","doi-asserted-by":"publisher","first-page":"7841718","DOI":"10.1155\/2016\/7841718","volume":"2016","author":"DP Misra","year":"2016","unstructured":"Misra DP, Chaurasia S, Misra R (2016) Increased circulating Th17 cells, serum IL-17A, and IL-23 in Takayasu arteritis. Autoimmune Dis 2016:7841718. https:\/\/doi.org\/10.1155\/2016\/7841718","journal-title":"Autoimmune Dis"},{"key":"6202_CR51","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00228-006-0192-1","volume":"62","author":"M Drozdzik","year":"2006","unstructured":"Drozdzik M, Rudas T, Pawlik A et al (2006) The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs. Eur J Clin Pharmacol 62:933\u2013937. https:\/\/doi.org\/10.1007\/s00228-006-0192-1","journal-title":"Eur J Clin Pharmacol"},{"key":"6202_CR52","first-page":"546","volume":"24","author":"R Takatori","year":"2006","unstructured":"Takatori R, Takahashi KA, Tokunaga D et al (2006) ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Clin Exp Rheumatol 24:546\u2013554","journal-title":"Clin Exp Rheumatol"},{"key":"6202_CR53","first-page":"930","volume":"62","author":"XY Yang","year":"2007","unstructured":"Yang XY, Xu DH (2007) MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus. Pharmazie 62:930\u2013932","journal-title":"Pharmazie"},{"key":"6202_CR54","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1590\/s0100-879x2008000900005","volume":"41","author":"TP Gonzalez","year":"2008","unstructured":"Gonzalez TP, Mucenic T, Brenol JC, Xavier RM, Schiengold M, Chies JA (2008) ABCB1 C1236T, G2677T\/A and C3435T polymorphisms in systemic lupus erythematosus patients. Braz J Med Biol Res 41:769\u2013772. https:\/\/doi.org\/10.1590\/s0100-879x2008000900005","journal-title":"Braz J Med Biol Res"},{"key":"6202_CR55","first-page":"572","volume":"35","author":"P Ranganathan","year":"2008","unstructured":"Ranganathan P, Culverhouse R, Marsh S et al (2008) Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol 35:572\u2013579","journal-title":"J Rheumatol"},{"key":"6202_CR56","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1007\/s00296-011-2088-3","volume":"32","author":"J Chen","year":"2012","unstructured":"Chen J, Chen L, Mao N, Liu Y (2012) Association of the MDR1 3435 polymorphism in patients with refractory rheumatoid arthritis in a Chinese population. Rheumatol Int 32:3127\u20133130. https:\/\/doi.org\/10.1007\/s00296-011-2088-3","journal-title":"Rheumatol Int"},{"key":"6202_CR57","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/1756-185x.12362","volume":"17","author":"S Prasad","year":"2014","unstructured":"Prasad S, Tripathi D, Rai MK, Aggarwal S, Mittal B, Agarwal V (2014) Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate. Int J Rheum Dis 17:878\u2013886. https:\/\/doi.org\/10.1111\/1756-185x.12362","journal-title":"Int J Rheum Dis"},{"key":"6202_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/bf00262714","volume":"15","author":"C Jorgensen","year":"1995","unstructured":"Jorgensen C, Sun R, Rossi JF et al (1995) Expression of a multidrug resistance gene in human rheumatoid synovium. Rheumatol Int 15:83\u201386. https:\/\/doi.org\/10.1007\/bf00262714","journal-title":"Rheumatol Int"},{"key":"6202_CR59","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/1529-0131(199909)42:9<2014::AID-ANR32>3.0.CO;2-R","volume":"42","author":"K Yudoh","year":"1999","unstructured":"Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T (1999) Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis. Arthritis Rheum 42:2014\u20132015. https:\/\/doi.org\/10.1002\/1529-0131(199909)42:9%3c2014::AID-ANR32%3e3.0.CO;2-R","journal-title":"Arthritis Rheum"},{"key":"6202_CR60","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/art.21032","volume":"52","author":"S Tsujimura","year":"2005","unstructured":"Tsujimura S, Saito K, Nakayamada S, Nakano K, Tanaka Y (2005) Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Arthritis Rheum 52:1676\u20131683. https:\/\/doi.org\/10.1002\/art.21032","journal-title":"Arthritis Rheum"},{"key":"6202_CR61","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1136\/ard.2005.049189","volume":"65","author":"SL Hider","year":"2006","unstructured":"Hider SL, Owen A, Hartkoorn R et al (2006) Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug. Ann Rheum Dis 65:1390\u20131393. https:\/\/doi.org\/10.1136\/ard.2005.049189","journal-title":"Ann Rheum Dis"},{"key":"6202_CR62","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1248\/bpb.31.873","volume":"31","author":"K Henmi","year":"2008","unstructured":"Henmi K, Yoshida M, Yoshikawa N, Hirano T (2008) P-glycoprotein functions in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus. Biol Pharm Bull 31:873\u2013878. https:\/\/doi.org\/10.1248\/bpb.31.873","journal-title":"Biol Pharm Bull"},{"key":"6202_CR63","first-page":"638","volume":"26","author":"MC Lu","year":"2008","unstructured":"Lu MC, Lai NS, Li KJ, Hsieh SC, Wu CH, Yu CL (2008) Increased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosus. Clin Exp Rheumatol 26:638\u2013645","journal-title":"Clin Exp Rheumatol"},{"key":"6202_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/ard.2007.070821","volume":"67","author":"S Tsujimura","year":"2008","unstructured":"Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y (2008) Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis 67:380\u2013388. https:\/\/doi.org\/10.1136\/ard.2007.070821","journal-title":"Ann Rheum Dis"},{"key":"6202_CR65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10067-008-1071-1","volume":"28","author":"V Agarwal","year":"2009","unstructured":"Agarwal V, Mittal SK, Misra R (2009) Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis. Clin Rheumatol 28:427\u2013433. https:\/\/doi.org\/10.1007\/s10067-008-1071-1","journal-title":"Clin Rheumatol"},{"key":"6202_CR66","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3899\/jrheum.090048","volume":"37","author":"K Suzuki","year":"2010","unstructured":"Suzuki K, Saito K, Tsujimura S et al (2010) Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis. J Rheumatol 37:512\u2013520. https:\/\/doi.org\/10.3899\/jrheum.090048","journal-title":"J Rheumatol"},{"key":"6202_CR67","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3892\/etm.2012.667","volume":"4","author":"B Zhang","year":"2012","unstructured":"Zhang B, Shi Y, Lei TC (2012) Detection of active P-glycoprotein in systemic lupus erythematosus patients with poor disease control. Exp Ther Med 4:705\u2013710. https:\/\/doi.org\/10.3892\/etm.2012.667","journal-title":"Exp Ther Med"},{"key":"6202_CR68","first-page":"101","volume":"20","author":"SM Ragab","year":"2013","unstructured":"Ragab SM, Soliman MA (2013) P-glycoprotein-1 functional activity in CD5+CD7+ and CD20+ lymphocytes in systemic lupus erythematosus children: relation to disease activity, complications and steroid response. Egypt J Immunol 20:101\u2013115","journal-title":"Egypt J Immunol"},{"key":"6202_CR69","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10067-015-3079-7","volume":"35","author":"A Kansal","year":"2016","unstructured":"Kansal A, Tripathi D, Rai MK, Agarwal V (2016) Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus. Clin Rheumatol 35:341\u2013349. https:\/\/doi.org\/10.1007\/s10067-015-3079-7","journal-title":"Clin Rheumatol"},{"key":"6202_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10238-017-0459-0","volume":"18","author":"EE Perez-Guerrero","year":"2018","unstructured":"Perez-Guerrero EE, Gamez-Nava JI, Mu\u00f1oz-Valle JF et al (2018) Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus. Clin Exp Med 18:109\u2013117. https:\/\/doi.org\/10.1007\/s10238-017-0459-0","journal-title":"Clin Exp Med"},{"key":"6202_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2010.10.001","volume":"138","author":"AP Diamanti","year":"2011","unstructured":"Diamanti AP, Rosado M, Germano V et al (2011) Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function. Clin Immunol 138:9\u201313. https:\/\/doi.org\/10.1016\/j.clim.2010.10.001","journal-title":"Clin Immunol"},{"key":"6202_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-05057-1","author":"S Edavalath","year":"2022","unstructured":"Edavalath S, Rai MK, Gupta V et al (2022) Tacrolimus induces remission in refractory and relapsing lupus nephritis by decreasing P-glycoprotein expression and function on peripheral blood lymphocytes. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-05057-1","journal-title":"Rheumatol Int"},{"key":"6202_CR73","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1007\/s10067-021-05743-2","volume":"40","author":"DP Misra","year":"2021","unstructured":"Misra DP, Rathore U, Patro P, Agarwal V, Sharma A (2021) Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis\u2014a systematic review and meta-analysis. Clin Rheumatol 40:4391\u20134416. https:\/\/doi.org\/10.1007\/s10067-021-05743-2","journal-title":"Clin Rheumatol"},{"key":"6202_CR74","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41590-020-00836-7","volume":"22","author":"E Kiner","year":"2021","unstructured":"Kiner E, Willie E, Vijaykumar B et al (2021) Gut CD4(+) T cell phenotypes are a continuum molded by microbes, not by T(H) archetypes. Nat Immunol 22:216\u2013228. https:\/\/doi.org\/10.1038\/s41590-020-00836-7","journal-title":"Nat Immunol"},{"key":"6202_CR75","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41590-020-00858-1","volume":"22","author":"JJP van Beek","year":"2021","unstructured":"van Beek JJP, Rescigno M, Lugli E (2021) A fresh look at the T helper subset dogma. Nat Immunol 22:104\u2013105. https:\/\/doi.org\/10.1038\/s41590-020-00858-1","journal-title":"Nat Immunol"},{"key":"6202_CR76","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/acr2.11296","volume":"3","author":"Y Gao","year":"2021","unstructured":"Gao Y, Dunlap G, Elahee M, Rao DA (2021) Patterns of T-cell phenotypes in rheumatic diseases from single-cell studies of tissue. ACR Open Rheumatol 3:601\u2013613. https:\/\/doi.org\/10.1002\/acr2.11296","journal-title":"ACR Open Rheumatol"},{"key":"6202_CR77","doi-asserted-by":"publisher","first-page":"eabf3041","DOI":"10.1126\/science.abf3041","volume":"376","author":"S Yazar","year":"2022","unstructured":"Yazar S, Alquicira-Hernandez J, Wing K et al (2022) Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease. Science 376:eabf3041. https:\/\/doi.org\/10.1126\/science.abf3041","journal-title":"Science"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06202-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T09:36:29Z","timestamp":1657877789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06202-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6202"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06202-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The funding agency had no role in the actual conduct or reporting of this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}